Lilly to launch new test of blood thinner
After reporting mixed results on a potentially lucrative blood thinner, Eli Lilly and Co. plans a new late-stage test of prasugrel for patients not receiving stents to open clogged heart arteries. Lilly and its development partner, Daiichi Sankyo Co. Ltd., plan to submit the drug for regulatory approval before the end of this year; the […]